These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 10651984)
1. Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells. Folini M; Colella G; Villa R; Lualdi S; Daidone MG; Zaffaroni N J Invest Dermatol; 2000 Feb; 114(2):259-67. PubMed ID: 10651984 [TBL] [Abstract][Full Text] [Related]
2. Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells. Yeo M; Rha SY; Jeung HC; Hu SX; Yang SH; Kim YS; An SW; Chung HC Int J Cancer; 2005 Apr; 114(3):484-9. PubMed ID: 15551309 [TBL] [Abstract][Full Text] [Related]
3. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells. Yokoyama Y; Takahashi Y; Shinohara A; Lian Z; Wan X; Niwa K; Tamaya T Cancer Res; 1998 Dec; 58(23):5406-10. PubMed ID: 9850072 [TBL] [Abstract][Full Text] [Related]
4. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells. Kanazawa Y; Ohkawa K; Ueda K; Mita E; Takehara T; Sasaki Y; Kasahara A; Hayashi N Biochem Biophys Res Commun; 1996 Aug; 225(2):570-6. PubMed ID: 8753802 [TBL] [Abstract][Full Text] [Related]
5. Synthetic 2'-O-methyl-modified hammerhead ribozymes targeted to the RNA component of telomerase as sequence-specific inhibitors of telomerase activity. Wan MS; Fell PL; Akhtar S Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):309-17. PubMed ID: 9743468 [TBL] [Abstract][Full Text] [Related]
6. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells. Hayashidani Y; Hiyama E; Murakami Y; Sueda T Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061 [TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA. Nosrati M; Li S; Bagheri S; Ginzinger D; Blackburn EH; Debs RJ; Kashani-Sabet M Clin Cancer Res; 2004 Aug; 10(15):4983-90. PubMed ID: 15297398 [TBL] [Abstract][Full Text] [Related]
8. [Inhibition of telomerase activity by ribozyme targeted to human telomerase transcriptase]. Qu Y; Liu SQ; Peng WZ; Liu BL Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 May; 34(3):323-8. PubMed ID: 12019445 [TBL] [Abstract][Full Text] [Related]
9. [Application of hammerhead ribozyme targeting telomerase molecule for cancer therapy]. Yokoyama Y; Takahashi Y; Shinohara A; Tamaya T Nihon Rinsho; 1998 May; 56(5):1126-30. PubMed ID: 9613108 [TBL] [Abstract][Full Text] [Related]
10. Hammerhead ribozymes to modulate telomerase activity of endometrial carcinoma cells. Yokoyama Y; Wan X; Shinohara A; Takahashi Y; Tamaya T Hum Cell; 2001 Sep; 14(3):223-31. PubMed ID: 11774741 [TBL] [Abstract][Full Text] [Related]
11. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells. Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of telomerase activity by geldanamycin and 17-allylamino, 17-demethoxygeldanamycin in human melanoma cells. Villa R; Folini M; Porta CD; Valentini A; Pennati M; Daidone MG; Zaffaroni N Carcinogenesis; 2003 May; 24(5):851-9. PubMed ID: 12771028 [TBL] [Abstract][Full Text] [Related]
13. Non-enzymatic in vitro production of circular hammerhead ribozyme targeting the template region of human telomerase RNA. Ochi A; Umekage S; Kikuchi Y Nucleic Acids Symp Ser (Oxf); 2009; (53):275-6. PubMed ID: 19749367 [TBL] [Abstract][Full Text] [Related]
14. [Study on telomerase inhibition by ribozyme targeted to telomerase RNA component]. Qu Y; OuYang X; Liu S; Peng X; Liu B Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Jun; 16(3):133-7. PubMed ID: 10359859 [TBL] [Abstract][Full Text] [Related]
15. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity. Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604 [TBL] [Abstract][Full Text] [Related]
16. Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression. Pennati M; Binda M; Colella G; Folini M; Citti L; Villa R; Daidone MG; Zaffaroni N J Invest Dermatol; 2003 Apr; 120(4):648-54. PubMed ID: 12648230 [TBL] [Abstract][Full Text] [Related]
17. Divalent hammerhead ribozyme targeting template region of human telomerase RNA has potent cleavage activity, but less inhibitory activity on telomerase. Yokoyama Y; Wan X; Takahashi Y; Shinohara A; Liulin T; Tamaya T Arch Biochem Biophys; 2002 Sep; 405(1):32-7. PubMed ID: 12176054 [TBL] [Abstract][Full Text] [Related]
18. Intensive inhibition of hTERT expression by a ribozyme induces rapid apoptosis of cancer cells through a telomere length-independent pathway. Hao ZM; Luo JY; Cheng J; Li L; He D; Wang QY; Yang GX Cancer Biol Ther; 2005 Oct; 4(10):1098-103. PubMed ID: 16205109 [TBL] [Abstract][Full Text] [Related]
19. Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo. Pennati M; Binda M; De Cesare M; Pratesi G; Folini M; Citti L; Daidone MG; Zunino F; Zaffaroni N Carcinogenesis; 2004 Jul; 25(7):1129-36. PubMed ID: 14764461 [TBL] [Abstract][Full Text] [Related]
20. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase. Ludwig A; Saretzki G; Holm PS; Tiemann F; Lorenz M; Emrich T; Harley CB; von Zglinicki T Cancer Res; 2001 Apr; 61(7):3053-61. PubMed ID: 11306487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]